Phase 3 trial
A clinical trial phase designed to evaluate the efficacy and safety of a new treatment in a large group of people, typically comparing it to standard treatments or placebos. Positive results in this phase are critical for regulatory approval.
Recent Developments
Moderna and Merck mRNA Vaccine
Significant progress has been made in the adjuvant therapy for resected-melanoma using personalized mRNA technology.
- Trial Outcome: Positive Phase 3 trial results announced for the combination of Moderna/Merck’s personalized mRNA cancer vaccine (Intismeran Autogene) and Merck’s Keytruda (pembrolizumab).
- Indication: Adjuvant therapy for patients with resected melanoma.
- Significance: Represents a major advancement in personalized cancer vaccines, potentially setting a new standard for post-surgical treatment to prevent recurrence.
- Source Context: Discussed in detail in the video Moderna Merck mRNA Cancer Vaccine and Keytruda for Resected Melanoma Adjuvant Therapy.
Related Concepts
- Clinical Trial Phases
- Immunotherapy
- Personalized Medicine
- Melanoma Treatment